✦ LIBER ✦

Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma

✍ Scribed by Hani Hassoun; Lilian Reich; Virginia M. Klimek; Madhav Dhodapkar; Adam Cohen; Tarun Kewalramani; Rachel Zimman; Lisa Drake; Elyn R. Riedel; Cyrus V. Hedvat; Julie Teruya-Feldstein; Daniel A. Filippa; Martin Fleisher; Stephen D. Nimer; Raymond L. Comenzo

Book ID: 108673525
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 140 KB
Volume: 132
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2005.05848.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bendamustine, Thalidomide and Dexamethas

Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma

✍ Elisabeth Grey-Davies; Jennifer L. Bosworth; Kevin D. Boyd; Caroline Ebdon; Rado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Tumor lysis syndrome following thalidomi

Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma

✍ Alissa Huston; Jason Brown; G. David Roodman 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A modified regimen of pegylated liposoma

A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients

✍ James R. Berenson; Ori Yellin; Chien-Shing Chen; Ravi Patel; Alberto Bessudo; Ra 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Bortezomib, doxorubicin, and dexamethaso

Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety

✍ Sung Sook Lee; Cheolwon Suh; Bong-Seog Kim; Jooseop Chung; Young-Don Joo; Hun-Mo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 151 KB

VTD combination therapy with bortezomib–

VTD combination therapy with bortezomib–thalidomide–dexamethasone is highly effective in advanced and refractory multiple myeloma

✍ Pineda-Roman, M; Zangari, M; van Rhee, F; Anaissie, E; Szymonifka, J; Hoering, A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 279 KB

A modified regimen of pegylated liposoma

A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma

✍ Gabriel N. Waterman; Ori Yellin; Regina A. Swift; Russell Mapes; Benjamin Eades; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 206 KB